Alzheimer’s disease Dementia MGC Pharmaceuticals

MGC Pharmaceuticals receives approval for Phase II trial of CogniCann

MGC Pharmaceuticals (MXC) has received approval from the University of Notre Dame in Western Australia’s (UNDA) Human Research Ethics Committee…